Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2010-08-24Clinical Trial Update: A Controlled Study of Quality of Life and it's Related Factors Among Gynecological Cancer Survivors
This clinical trial update investigates quality of life and related factors among gynecologic cancer survivors. The study includes cervical,…
-
CLINICAL_TRIALS trial_result · 2010-08-12Clinical Trial Update: Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian Cancer [Phase 2]
A Phase 2 trial update on consolidation Whole Abdominal IMRT for advanced ovarian cancer, including fallopian tube cancer and primary perito…
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: Effects of a Teaching Intervention With an Advanced Practice Nurse on Quality of Life and Psychosocial and Symptom Distress in Patients With Ovarian Cancer [NA]
A completed trial evaluating whether an advanced practice nurse–led teaching intervention improves quality of life and reduces psychosocial …
-
CLINICAL_TRIALS research · 2010-08-10Clinical Trial Update: Early Detection of Cancers in Low Resource Countries
This update covers a clinical trial evaluating early detection strategies for breast, cervical, ovarian, and endometrial cancers in low-reso…
-
CLINICAL_TRIALS trial_result · 2010-08-03Clinical Trial Update: Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. [Phase 1]
Phase 1 trial assessing safety and immune response of MKC1106-PP in patients with advanced cancer, including ovarian cancer and melanoma; th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-07-26Clinical Trial Update: Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer [Phase 1]
Phase I study of CDX-1307, an hCG-B vaccine, in patients with incurable locally advanced or metastatic breast, colorectal, pancreatic, bladd…
-
CLINICAL_TRIALS trial_result · 2010-07-26Clinical Trial Update: A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01) [Phase 1]
This update summarizes a Phase 1 study of CDX-1307 in patients with incurable breast, colorectal, pancreatic, ovarian, or bladder cancer. Th…
-
CLINICAL_TRIALS trial_result · 2010-07-20Clinical Trial Update: Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours [Phase 2]
Phase 2 trial evaluating combination chemotherapy with pegylated liposomal doxorubicin and carboplatin in malignant gynecologic tumors has c…
-
CLINICAL_TRIALS trial_result · 2010-07-20Clinical Trial Update: A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy [Phase 2]
A phase II trial assessing gefitinib (ZD1839) in combination with tamoxifen for epithelial ovarian cancer, fallopian tube cancer, or periton…
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Caelyx in Ovarian Cancer: Prevention and Treatment of Infusion Reactions and Palmar-plantar Erythrodysesthesia (Study P04085)(COMPLETED)
Completed study P04085 evaluated Caelyx (liposomal doxorubicin) in ovarian cancer, focusing on prevention and treatment of infusion reaction…
-
CLINICAL_TRIALS trial_result · 2010-06-04Clinical Trial Update: Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer Patients [Phase 2]
Phase 2 trial evaluating carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer has completed. The summary notes the sta…
-
CLINICAL_TRIALS research · 2010-06-03Clinical Trial Update: Thymidine Kinase 1 in Risk Assessment for Hereditary Breast /Ovarian Cancer
This clinical trial update discusses using thymidine kinase 1 as a biomarker for risk assessment in hereditary breast and ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2010-05-07Clinical Trial Update: Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer [Phase 1]
Phase 1 clinical trial evaluating cellular adoptive immunotherapy for stage III/IV ovarian cancer or primary peritoneal cancer has completed…
-
CLINICAL_TRIALS trial_result · 2010-04-23Clinical Trial Update: Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers [Phase 2]
Phase 2 clinical trial update evaluating chemotherapy with whole-body hyperthermia for resistant breast, endometrial, cervical, and ovarian …
-
CLINICAL_TRIALS trial_result · 2010-04-09Clinical Trial Update: A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma [Phase 2]
A Phase 2 study sponsored by Eli Lilly in patients with persistent or recurrent epithelial ovarian cancer or primary peritoneal carcinoma ha…
-
CLINICAL_TRIALS trial_result · 2010-04-08Clinical Trial Update: Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer [Phase 2]
Phase II trial evaluating an EGFR-targeted therapy in patients with advanced ovarian, primary peritoneal, and fallopian tube cancers; the st…
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors [Phase 2]
Phase 2 trial update evaluating Interleukin-11 plus filgrastim as a pre-transplant regimen for patients undergoing peripheral stem cell tran…
-
FDA approval · 2010-03-26FDA Approved: HYCAMTIN — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for HYCAMTIN (topotecan hydrochloride) submitted by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2010-03-24Clinical Trial Update: Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries [NA]
A completed clinical trial assessing fenretinide for preventing ovarian cancer in women at high risk (BRCA1/BRCA2 carriers) undergoing oopho…
-
CLINICAL_TRIALS trial_result · 2010-03-17Clinical Trial Update: Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer [Phase 2]
Phase 2 trial evaluating fulvestrant for recurrent ovarian epithelial cancer has completed with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial of exemestane (Aromasin) in patients with recurrent or refractory stage II-IV epithelial ovarian cancer; the study status is c…
-
CLINICAL_TRIALS trial_result · 2010-02-26Clinical Trial Update: CT-2106 for the Second Line Treatment of Ovarian Cancer [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating CT-2106 as second-line therapy for ovarian cancer. It notes CTI …
-
CLINICAL_TRIALS research · 2010-02-24Clinical Trial Update: Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182
Clinical trial update examining biomarkers that may predict response to treatment in advanced ovarian epithelial cancer, fallopian tube canc…
-
CLINICAL_TRIALS trial_result · 2010-02-22Clinical Trial Update: Study of XL999 in Patients With Previously Treated Ovarian Cancer [Phase 2]
A Phase 2 study of XL999 in previously treated ovarian cancer was terminated.
-
CLINICAL_TRIALS research · 2010-02-09Clinical Trial Update: Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass [NA]
Clinical trial update describing the use of proteomic profiling to help diagnose ovarian cancer in patients undergoing surgery for an abnorm…